Evaxion Biotech A/S

NASDAQ: EVAX · Real-Time Price · USD
2.88
0.02 (0.70%)
At close: Aug 15, 2025, 3:59 PM
2.84
-1.39%
After-hours: Aug 15, 2025, 04:10 PM EDT

Evaxion Biotech A/S Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Nov 14, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a 122K 3.03M 153.89K 50.88K 73.6K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a 122K 3.03M 153.89K 50.88K 73.6K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-3.87M -4.02M -1.74M -4.58M -4.39M -4.4M -5.76M -5.68M -6.39M -6.53M -6.08M -6.26M -6.4M -7.72M -5.91M -7.03M -5.17M
Interest Income
2.49M n/a 84.26K 41K 5.62M 541.33K 72K 47K 285K 70K 703K 1.54M 519K 746K 288K 33K 972K
Pretax Income
-1.77M -3.9M -2.04M -6.39M 973.73K -4.74M -5.87M -5.91M -6.43M -7.04M -5.92M -4.95M -6.04M -7.05M -5.67M -7.49M -4.5M
Net Income
-1.58M -3.63M -1.94M -6.19M 1.19M -4.56M -5.68M -5.68M -6.24M -6.87M -5.74M -4.77M -5.79M -8.37M -5.25M -6.82M -4.09M
Selling & General & Admin
1.71M 1.59M 2.13M 1.98M 1.61M 2.16M 2.93M 2.74M 2.54M 2.45M 2.02M 2.15M 1.59M 1.57M 1.5M 1.92M 1.28M
Research & Development
2.16M 2.25M 2.62M 2.75M 2.83M 2.32M 2.83M 2.94M 3.85M 4.07M 4.07M 4.11M 4.8M 6.15M 4.42M 5.11M 3.89M
Other Expenses
n/a 302K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 71K n/a n/a n/a
Operating Expenses
3.87M 4.15M 4.76M 4.73M 4.44M 4.47M 5.76M 5.68M 6.39M 6.53M 6.08M 6.26M 6.4M 7.72M 5.91M 7.03M 5.17M
Interest Expense
397K n/a 385.21K 225K 246K 111K 182K 221K 326K 590K 535K 225K 158K 72K 51K 495K 297K
Selling & Marketing Expenses
n/a n/a n/a -1.45K -3.75K 292.52K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
3.87M 4.15M 4.76M 4.73M 4.44M 4.47M 5.76M 5.68M 6.39M 6.53M 6.08M 6.26M 6.4M 7.72M 5.91M 7.03M 5.17M
Income Tax Expense
-192K -275K -96.3K -198.85K -217.49K -178.45K -194K -225K -194K -173K -175K -177K -247K 1.32M -425K -669K -407K
Shares Outstanding (Basic)
1.11M 1.07M 1.38M 1.35M 1.17M 683.39K 691.5K 676.55K 644.6K 603.49K 595.84K 580.1K 579.1K 541.78K 479.97K 473.54K 444.89K
Shares Outstanding (Diluted)
1.11M 1.07M 1.38M 1.35M 1.17M 683.39K 691.5K 676.55K 644.6K 603.49K 595.84K 596K 579.1K 541.78K 479.97K 473.54K 444.89K
EPS (Basic)
-1.43 -3.4 -1.4 -4.56 1.04 -6.68 -8.2 -8.4 -9.68 -11.4 -9.64 -8.2 -10 -15.44 -10.92 -14.4 -9.2
EPS (Diluted)
-2.5 -3.4 -1.4 -4.56 1.04 -6.68 -8.2 -8.4 -9.68 -11.4 -9.64 -8 -10 -15.44 -10.92 -14.4 -9.2
EBITDA
-1.38M -5.61M -1.65M -4.54M 1.22M -4.26M -5.56M -5.63M -6.14M -6.51M -5.35M -4.69M -5.87M -7.68M -5.61M -6.98M -4.19M
EBIT
-1.38M -5.61M -1.65M -6.17M 1.22M -4.59M -5.69M -5.69M -6.11M -7.17M -5.38M -4.72M -5.88M -7.73M -5.62M -6.99M -4.2M
Depreciation & Amortization
n/a n/a 89.46K 37.66K 99.75K 99.75K 200K 150K 89.25K 89.25K 41.25K 41.25K 41.25K 41.25K 26.25K 8K 8K